Response to Toub re: “Update on Conservative Surgery for Fibroids: Laparoscopic Radiofrequency and Transcervical Fibroid Ablation”

Toub D . Response to Shukr Re: Update on conservative surgery for fibroids: Laparoscopic radiofrequency and transcervical fibroid ablation. J Gynecol Surg, 2024; online ahead of print; doi: 10.1089/gyn.2023.0131

Polin M , Hur HC . Radiofrequency ablation of uterine myomas and pregnancy outcomes: An updated review of the literature. J Minim Invasive Gynecol, 2022; 29(6):709–715; doi: 10.1016/j.jmig.2022.01.015

Stewart KA , Greenberg JA , Kho KA , et al. Radiofrequency ablation of leiomyomas. Obstet Gynecol, 2023; 141(6):1063–1071; doi: 10.1097/AOG.0000000000005196

Lukes A , Green MA . Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata. J Gynecol Surg, 2020; 36(5):228–233; doi: 10.1089/gyn.2020.0021

Piriyev E , Bends R , Schiermeier S , et al. Transcervical intrauterine radiofrequency ablation of fibroids in high-risk patients with bleeding disorder. Ginekol Pol, 2022; 93(8):614–619; doi: 10.5603/GP.a2022.0042

Fasciani A , Turtulici G , Pedullà A , et al. Uterine myoma position–based radiofrequency ablation (UMP-b RFA): 36 months follow-up clinical outcomes. Eur J Obstet Gynecol Reprod Biol, 2023; 281:23–28; doi: 10.1016/j.ejogrb.2022.12.006